Several U.S. drug companies are hard at work developing a vaccine to fight the coronavirus that is spreading around the world.
The European Commission has approved a U.S. company's first-ever Ebola vaccine, boosting efforts to fight the deadly virus.
The U.S. Food and Drug Administration has approved only its third anti-TB drug in more than 40 years, offering hope to patients once considered untreatable.
The U.S., the single-largest contributor to ongoing efforts in the fight against Ebola, calls on international partners to increase assistance.
Venezuela's economic collapse has left its people vulnerable to once eradicated diseases that could spread across the Americas.
New inventions from the global health startup community, with funding from USAID, are improving care — and outcomes — for Ebola patients in the DRC.
The United States is providing more money to help contain the Ebola outbreak in the Democratic Republic of the Congo and urging all World Health Organization members to join the fight.
April 25 is World Malaria Day. Learn how the U.S. President's Malaria Initiative is helping to protect communities against the deadly disease.
The U.S. and allies are weighing their response to a chemical attack in the town of Douma, Syria, that they believe was perpetrated by the Assad regime.